Global Oncology Molecular Diagnostics Market to Grow at 14.7% During 2022-2027, Fostered by Growing Awareness Regarding Early Cancer Detection

October 01, 2020

According to the latest report by IMARC Group, titled "Oncology Molecular Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global oncology molecular diagnostics market reached a value of US$ 3.2 Billion in 2021. Oncology molecular diagnostics is a part of laboratory medicine that involves analyzing biological markers for the detection of cancer cells in an individual. In this process, blood, saliva, and tumor tissue sample tests are performed on the patient for measuring specific genetic sequences in the DNA, RNA and cell proteins. They are utilized for performing rapid analysis of the condition and providing detailed critical information regarding it. The quantitative measurements offered by the diagnostics are essential in understanding the stage and available effective therapeutic options for cancer. This aids in determining the right course of personalized treatment for the patient by making informed medical decisions for a better outcome.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global Oncology Molecular Diagnostics Market Trends:

The market is primarily driven by the growing prevalence of different forms of cancer across the globe. This can be attributed to the sedentary lifestyles led by the majority of the population, along with the high tobacco and alcohol uptake by the masses. Consequently, there is a significant increase in the demand for efficient diagnostic solutions, thereby providing a thrust to the market growth. Apart from this, the rising awareness regarding early cancer detection among individuals is acting as another major growth-inducing factor. Moreover, there has also been a considerable increase in the geriatric population on the global level. This, along with the growing investments by numerous private and public organizations to develop the oncology infrastructure across healthcare facilities, is creating a positive outlook for the market. Numerous players have also introduced technologically advanced diagnostics products in the market. Since these products offer enhanced accuracy and speed in terms of diagnosis while being affordable, they are gaining widespread prominence across the healthcare sector. Some of the other factors catalyzing the market growth include the increasing penetration of healthcare insurance in numerous developing countries and the rising trend of medical tourism on the global level. On account of the aforementioned factors, the market is anticipated to grow at  a CAGR of 14.7% during 2022-2027.

Marker Summary:

  • On the basis of the cancer type, the market has been divided into breast, prostate, colorectal, cervical, liver, lung, blood and other forms of cancer.
  • Based on the product, the market has been classified into instruments, reagents and others.
  • On the basis of the technology, the market has been categorized into polymerase chain reaction (PCR), in situ hybridization, chips and microarrays, isothermal nucleic acid amplification technology (INAAT), mass spectrometry, DNA and NGS sequencing, transcription mediated amplification (TMA) and others.
  • Based on the end-user, the market has been segmented into hospitals and clinics, reference laboratories, and others.
  • On the geographical front, the market has been segregated into North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Latin America (Brazil, Mexico and others), and Middle East and Africa.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players. Some of these players include Agilent Technologies, Inc., Abbott Laboratories, Bayer AG, Becton, Dickinson and Company, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic, Inc., Qiagen N.V., Siemens Healthcare and Sysmex Corporation.
     

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Global Oncology Molecular Diagnostics Market to Grow at 14.7% During 2022-2027, Fostered by Growing Awareness Regarding Early Cancer Detection
Select Licence Type



Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More